Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
clinical trials
eli lilly
3
×
life sciences
national blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
fremanezumab
indiana blog main
indiana top stories
migraine
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alder biopharmaceutical
What
companies
3
×
drug
new
3
×
approval
arguments
big
bio
biogen’s
biopharmaceutical
biotech
black
cancer
class
clinic
commercialized
competitors
convo
decades
diamond
drugs
earlier
eluded
failures
fda
hopes
ipo
lead
leading
lines
littered
make
medicines
meeting
migraine
molecular
nash
nears
neuro
news
oral
Language
unset
Current search:
biotech
×
companies
×
" eli lilly "
×
new
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More